Showing results (341-350 of 495) with videos related to
Sort By:
Pageof 50
Plos One|December 19, 2013
Mutation inactivation of Nijmegen breakage syndrome gene (NBS1) in hepatocellular carcinoma and intrahepatic cholangiocarcinomaYan Wang, Yu Hong, Man Li, et al.Journal of Digestive Diseases|April 10, 2025
Etiology Control for Reducing Hepatic Vein Pressure Gradient in Patients With Cirrhosis and Portal Hypertension: A Systematic Review and Meta-AnalysisShuai Xia, Zhi Ying He, Xiao Ning Wu, et al.World Journal of Surgical Oncology|February 4, 2014
Protective effect of S-adenosylmethionine on hepatic ischemia-reperfusion injury during hepatectomy in HCC patients with chronic HBV infectionGuo-yan Liu, Wei Wang, Wei-dong Jia, et al.Biomedical and Environmental Sciences : BES|April 21, 2018
Subchronic Oral Toxicity of Silica Nanoparticles and Silica Microparticles in RatsChun Lai Liang, Qian Xiang, Wen Ming Cui, et al.Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|October 1, 2005
[Prevention and treatment of hepatitis B virus reinfection after liver transplantation]Jian Liu, Guo-cong Wu, Zhong-tao Zhang, et al.Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 18, 2004
Impact of virus genotype on interferon treatment of patients with chronic hepatitis C: a multicenter controlled studyYao Xie, Dao-Zhen Xu, Zhi-Meng Lu, et al.The Oncologist|September 2, 2025
Impact of Temporary Atezolizumab and Bevacizumab Interruption on Survival in Advanced HCC: An IMbrave150 AnalysisXiao-Qian Xu, Wei-Ming Li, Li-Chen Shi, et al.Digestive Diseases and Sciences|December 5, 2008
Antitumoral activity of rapamycin mediated through inhibition of HIF-1alpha and VEGF in hepatocellular carcinomaWei Wang, Wei-Dong Jia, Ge-Liang Xu, et al.Surgery|March 21, 2015
Sustained methylene blue staining to guide anatomic hepatectomy for hepatocellular carcinoma: Initial experience and technical detailsCai Shou-wang, Yang Shi-zhong, Lv Wen-ping, et al.Hepatobiliary & Pancreatic Diseases International : HBPD INT|May 24, 2005
Predictive factors for sustained response to interferon treatment in patients with chronic hepatitis C: a randomized, open, and multi-center controlled trialYao Xie, Dao-Zhen Xu, Zhi-Meng Lu, et al.Pageof 50